Objective The blood-brain barrier (BBB) and blood-nerve barrier (BNB) play crucial roles in the maintenance of the central and peripheral nervous system. It had previously been thought that the BNB was leaky compared with the BBB, but several recent reports showed that the BNB has almost the same properties as a barrier system as the BBB, suggesting that the specific structural component of the basement membrane (especially laminin) in the BNB acts as a distinct barrier. Although the role of the laminin isoforms has been linked to BBB, the laminins in the BNB still remain unknown. Here, we aim to show the laminin components in the BNB and BBB. Methods The laminin isoforms (a5, a4, b1, b2 and c1) were immunohistochemically analyzed in the brain and a median nerve specimen of a postmortem amyotrophic lateral sclerosis patient. Then the expression of these laminin isoforms was scrutinized in sural nerve specimens of some peripheral neuropathies. Results The present histological data showed that laminin a4 was hardly present in BNB compared with BBB, whereas other laminin isoforms were widely expressed in BBB and BNB. Additionally, laminin a4 in BNB decreased in both amyotrophic lateral sclerosis and the peripheral neuropathies in which the BNB was supposed to be broken down. Conclusions Laminin a4 did not decrease in BBB, but did decrease in BNB in the patients with or without peripheral neuropathies. As previous reports showed that laminin a4 is essential for T lymphocytes to migrate across the BBB, these results suggested that BNB might have a distinct mechanism for T cell migration that does not require laminin a4.
Introduction
The blood-brain barrier (BBB) and blood-nerve barrier (BNB) restrict exchanges of soluble factors and white blood cells between the blood and neural tissue parenchyma, playing a crucial role in the maintenance of central and peripheral nervous system homeostasis. BBB is mainly composed of brain microvascular endothelial cells, pericytes, astrocytes and the two distinct basement membranes. BNB has a similar structure as the BBB with the exception of lacking astrocytes and the glia limitans formed by astrocytes. In neuroinflammatory diseases, disruption of the BBB/BNB is the initial key step in the development of inflammatory lesions.
It had previously been thought that the BNB was leaky compared with the BBB as a result of the lack of astrocytes, but several recent reports showed that the BNB has almost the same properties as a barrier system as those with BBB, suggesting that the specific structural component of the basement membrane at the BNB affects barrier function. 1 The basement membrane consists of a mixture of extracellular matrix proteins, including laminin and collagen IV. [2] [3] [4] [5] Laminin is a trimeric molecule comprised of a-, band c-subunits, and shows specific expression in the central and peripheral nervous system.
Recently, some reports showed that laminins were relevant for BBB integrity. In laminin a4-deficient mice, compensatory expression of laminin a5 is found in the endothelial cell basement membranes of the central nervous system, the experimental autoimmune encephalomyelitis progression was ameliorated in association with a reduction of cellular infiltrates. 6, 7 In another article, the authors showed that laminin a5, b1 and c1 (511) plays a key role in the maintenance and repair of BBB after hypoxic injury and inflammation. 8 These results suggested that laminin isoforms might act as a distinct barrier of the BBB. Although the role of the laminin isoforms has been linked to BBB under physiological and pathological conditions, the components of laminins in the BNB still remain elusive. Here, we histologically analyzed the laminin components in the BNB and BBB.
Methods

Patients
All patients enrolled in the present study were diagnosed at the Yamaguchi University Hospital, Yamaguchi, Japan, during 2008-2016. Autopsy specimens of the brain and median nerve were obtained from a post-mortem amyotrophic lateral sclerosis (ALS) patient (male; age 67 years) as a representative of non-peripheral neuropathy. Diabetic neuropathy, vitamin B 1 deficiency, alcoholic neuropathy and chronic inflammatory demyelinating polyneuropathy Figure 1 Immunostaining with anti-laminin (a5,4, b1,2 and c1) in brain (left side) and median nerve (right side) from a postmortal 67-year-old man with ALS. Laminin a5 immunoreactivity was localized to the microvessels. Only laminin a4 immunoreactivity was lost in the BNB. Bar, 10 lm. Figure 2 Immunostaining with anti-laminin (a5 and 4) in sural nerves from a 67-year-old man with DM, a 60-year-old man with vitamin B 1 deficiency, a 60-year-old man with alcoholic neuropathy and a 55-yearold man with CIDP. The laminin a5 immunoreactivity was localized to the microvessels in the BNB in these peripheral neuropathies. The laminin a4 immunoreactivity in these neuropathies was lost in the BNB. Bar, 10 lm.
were chosen as representative peripheral neuropathies. Sural nerve biopsy specimens were obtained from four neuropathy patients including diabetic neuropathy (female; age 64 years), vitamin B 1 deficiency (female; age 58 years), alcoholic neuropathy (male; age 60 years) and chronic inflammatory demyelinating polyneuropathy (male; age 55 years). Diagnoses were based on detailed clinical and electrophysiological investigations of the patients, in addition to the pathological examination of sural nerve specimens. Specimens were snap frozen and stored at À80°C until use. 10465-1-1p) was purchased from Proteintech (Rosemont, IL, USA). Mouse monoclonal antibodies against human laminin a5 (a5-chain: MAB1924) were purchased from Millipore (Temecula, CA, USA). Serial transverse sections (10-lm thick) were cut from specimens on a cryostat, fixed in acetone at 4°C for 5 min and then exposed to 0.03% H 2 O 2 / methanol for 10 min at room temperature. Sections were then pre-incubated in phosphate-buffered saline supplemented with 10% normal goat serum for 3 h before incubating overnight with primary antibody diluted in phosphate-buffered saline. Antilaminin c1, anti-laminin b1 and anti-laminin b2 antibodies were used at a 1/100 dilution, whereas others were used at a 1/500 dilution. Sections were then rinsed with phosphate-buffered saline three times before incubation for 1 h with peroxidase conjugated secondary antibody (Nichirei, Tokyo, Japan). The reaction product showing immunoreactivity in sections was developed with diaminobenzidine. Figure 3 Immunostaining with anti-laminin (b1, b2 and c1) in sural nerves from DM, vitamin B1 deficiency, alcoholic neuropathy and CIDP. Each laminin isoform was detected in the microvessels in these peripheral neuropathies. Bar, 10 lm.
Immunohistochemical techniques
Results
Laminin isoforms in BBB and BNB
We carried out the immunostaining with anti-laminin (a5, a4, b1, b2 and c1) antibodies in the brain (BBB) and median nerve (BNB) from a 67-year-old man with ALS (Fig. 1) . Laminin a5 immunoreactivity was localized to the microvessels. Only laminin a4 immunoreactivity was lost in the BNB.
Comparison of laminin a5 and a4 expression in the BNB in peripheral neuropathies
Immunostaining was shown with anti-laminin (a5 and a4) in the sural nerves from a 67-year-old man with diabetic neuropathy, a 60-year-old man with vitamin B 1 deficiency, a 60-year-old man with alcoholic neuropathy and a 55-year-old man with chronic inflammatory demyelinating polyneuropathy (Fig. 2) . Laminin a5 immunoreactivity was localized to the microvessels in the BNB. Laminin a4 immunoreactivity was lost in the BNB in these peripheral neuropathy specimens. To evaluate the expression of other laminins (b1, b2 and c1) in the BNB of these neuropathies, immunocytochemistry was carried out (Fig. 3) . The expression of each laminin isoform (b1, b2 and c1) in the BNB was confirmed. There was no marked difference among these neuropathies.
Discussion
Our histological data showed that laminin a4 was hardly expressed in the BNB, compared with the BBB, whereas a5, b1, b2 and c1 were widely expressed in the BBB and BNB. Additionally, laminin a4 decreased in both ALS and peripheral neuropathies. Generally, laminins a4 and a5 are generated by brain microvascular endothelial cells and pericytes, 9,10 whereas astrocytes produce laminins a1 and a2. 10, 11 These laminin compositions are all expressed by primary brain capillary pericytes. 12 In experimental autoimmune encephalomyelitis, a relevant preclinical model of multiple sclerosis, laminin a4 facilitates the transmigration of T lymphocytes across the BBB, because integrin a6b1, a major counterpart receptor of laminin a4, is strongly expressed on all T lymphocytes. 6 These results
showed that T lymphocytes with integrin a6b1 migrated across the BNB through other factors, except for laminin a4 in peripheral autoimmune neuropathies, suggesting that BNB has its own barrier system because of a lack of laminin a4 in BNB.
Some reports showed that BNB was affected by a variety of factors. In diabetic patients, advanced glycation end-products are non-enzymatically produced. 13 Advanced glycation end-products increased the expression of basement membrane molecules including fibronectin and collagen type IV in pericytes through transforming growth factor-b and vascular endothelial growth factor signaling, leading to a breakdown of BNB.
14 Taken together, we hypothesized that laminin components, other basement membrane molecules and humoral factors might determine a specific barrier system.
